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 Abstract Pulmonary rehabilitation (PR) may not suit all individuals with COPD 
and may not result in increased levels of physical activity. Higher levels of 
physical activity are associated with reduced mortality and morbidity in this 
population. The aim of this study was to assess the feasibility of conducting a 
trial to investigate the effectiveness of a clinician facilitated physical activity 
intervention (PAI) versus PR in improving physical activity in COPD patients 
referred to PR. In this randomised controlled mixed methods feasibility study all 
patients referred to PR who were eligible and willing to take part were assessed 
at baseline and then randomised to either the PAI or to PR. Assessments were 
repeated post intervention and at 3 month follow up. The main outcome was step 
count measured by the Actigraph. Semi structured interviews were conducted 
post intervention. N=50 patients; mean (SD) age 64.1(8.6)years, 24M were 
recruited and randomised; N=23 (PAI) and n=26 (PR); one patient was excluded 
from the analysis as they did not meet the GOLD diagnostic criteria for COPD. 
Key feasibility criteria were met; recruitment was 11%, dropouts in PAI were 
26% (n=6) and 50% (n=13/26) in PR.  Participants in both groups experienced a 
range of health benefits from their respective programmes. The PAI appears to 
be effective in increasing step counts in people with COPD: mean change 
(standard deviation) [confidence interval] for the PAI group was 972.0(3230.3)[-
1080.3 to 3024.4], n=12 and 4.3(662.7)[-440.9 to 449.5], n=11 for the PR group. 
The PAI met all domains of fidelity. This study provides key information to 









Globally, pulmonary rehabilitation (PR) is established as a core component in the 
management of COPD and has been shown to enhance health quality of life, reduce dyspnoea 
and improve exercise capacity [1]. There is limited evidence to indicate whether the improved 
exercise capacity following PR translates into improved daily physical activity levels in 
COPD [2, 3]. The majority of PR programmes are supervised outpatient-based, and delivered 
in a group format [4]. Not all patients referred to PR attend for assessment or enroll in the 
programme after assessment [5], dropouts from and non-adherence rates with PR are high, 
emphasising that PR may not suit all patients with COPD [5, 6]. Current capacity is unable 
reach all those with COPD who would potentially benefit from PR [5, 7] and so there is a 
need to explore alternative platforms for delivering exercise/physical activity interventions 
traditionally delivered in context of PR .  
 
Physical activity is fundamental for the prevention of chronic disease and premature 
mortality [8]. Walking represents a form of physical activity that has been shown to be 
effective in increasing physical activity in clinical populations and is necessary for activities 
of daily living [9]. Although studies in COPD have demonstrated the effectiveness of physical 
activity interventions [10] particularly individualised walking programmes [11, 12], these 
alternative programmes do not seem to be offered within current models of healthcare 
provision for COPD.  Interventions have also included different components, for example, use 
of the internet to record and facilitate the intervention [13], the use of pedometers [14, 15], 
and various behavior change strategies [16, 17]. However to date a home-based pedometer 
driven walking intervention in comparison to PR has not yet been explored. A home-based 
pedometer-driven walking intervention may offer an innovative and alternative method of 
delivering physical activity training that could be provided to large numbers of patients with 
COPD on an individual basis. Walking could provide for flexibility around life commitments 
and promote a change in activity levels.  
 
The importance of conducting a feasibility study prior to a full randomised controlled 
trial (RCT) has been emphasised by key funders such as the Medical Research Council and 
the National Institute for Health Research (NIHR), as well as recent publications [18-21]. 
Mixed methods designs can be used in feasibility studies to allow for a greater understanding 
of patients’ perceptions of feasibility, for example barriers to participation [22]. Therefore the 
aim of this study is to assess the feasibility of conducting a trial to investigate the 
effectiveness of a clinician facilitated physical activity intervention (PAI) (physical activity 
consultation and a pedometer-based walking programme) versus PR in improving physical 
activity in COPD patients referred to PR. 
Objectives  
I. To use the NIHR criteria (Table 1) to assess the feasibility of conducting a trial to 
compare the effectiveness of PAI versus PR in patients with COPD referred to PR 
(LIVELY COPD project). 
II. To explore the views and experience of participants relating to their satisfaction and 
perceived benefits of a PAI and of PR. 




The reporting of this trial adheres to the Template for Intervention Description and 
Replication (TIDieR) and the Consolidated Standards of Reporting Trials (CONSORT) 
statement  2010 [23, 24], online supplement eTable 1.  
Design 
The study design was a multicenter mixed methods randomised, parallel-group, feasibility 
study. The study was registered at https://clinicaltrials.gov/. Ethical approval was obtained 
from the Northern Ireland Research Ethics Committee 13/NI/0014. 
 
Population  
Patients with COPD (n=50) referred for PR to any of the eight sites that provide PR within 
two Health and Social Care (HSC) Trusts in Northern Ireland were included. All PR sites 
reported that they were adhering to the BTS guidelines for Pulmonary Rehabilitation prior to 
the commencement of and midway through the study [4]. Patients with a primary diagnosis of 
COPD, a good understanding of written English (as reported by the individual patient) and in 
a stable phase (no change in symptoms or medication in previous 4 weeks) at the time of 
assessment were included. Spirometry was provided by the PR team and when necessary 
COPD diagnosis was confirmed with the site PI. Exclusion criteria were inability to safely 
take part in a walking programme or PR (e.g. unstable angina, neurological, spinal or skeletal 
dysfunction affecting ability to exercise) as decided by the PR team or inability to 
comprehend or follow instructions (e.g. dementia).  
 
Recruitment and randomisation 
Participants were randomly assigned to two groups using computer-generated block random 
numbers by a member of team not involved in any other aspect of the study in order to ensure 
allocation concealment: Group 1-PAI or Group 2- PR. The allocation was retained in sealed 
envelopes which were opened to reveal group allocation only after consent and after 
completion of baseline assessment. Patients were stratified according to HSC Trust to help 
ensure that equal numbers of patients within each Trust were randomised to each group.  
 As this was a feasibility study, no formal sample size calculation was used. Based on 
previous publications a sample size of 50 was deemed appropriate to achieve the 
aims/objectives of this study [25]. This sample size also reflected a realistic target for the 
intervention period and one which was anticipated would provide sufficient information on 
the feasibility to inform future studies.  
 
Interventions:  
Participants were randomised to either the PAI or PR.  
Physical Acitivity Intervention  
The PAI intervention was a 12 week clinician facilitated pedometer driven walking 
programme. All participants were provided with an unsealed Yamax Digiwalker CW700 so 
they could record and see their daily step count during the PAI, and as a manual with weekly 
step diary and action and coping plans.  Per protocol participants had weekly contact with the 
interventionist (specifically trained physiotherapist or nurse (details on the training are 
available in 2)); weeks 1 to 6 were face to face, weeks 7-11 were conducted by telephone. 
Week 12, the final consultation was delivered face to face as planned. Individual face to face 
consultations were expected to last up to one hour and were conducted in an outpatient 
hospital department and telephone consultations were expected to last about 15-20 minutes 
and were iniated by the clinician at an agreed time. Consultations were expected to transition 
from face to face towards telephone based consultations by about week 6 anticipating that 
participants would become more familiar and more confident with the intervention, and also 
to offer flexibility. Regardless, all components of the consultatiions were expected to be 
delivered. The PAI considered the, 'capability', 'opportunity', 'motivation' and 'behaviour,' 
(COM-B) model of behaviour change [26] and included 20 behaviour change strategies [27]. 
Each week participants set a step goal based on their previous weeks step count, as well as the 
results of a self-efficacy walk (how many steps the participant walked in ten minutes) [9]. 
This step goal was individual to the patient. An example of how the weekly step goal was set 
is available in the eTable 3.  Participants wore pedometers each day during the intervention 
period for motivation and feedback, and also kept a written step diary which was contained 
with the intervention manual supplied to them.  At each subsequent consultation the clinicians 
and participants revisited the daily steps of the previous week and reviewed the step goal to 
assess if it was met/not met or partially met; barriers to physical activity were identified and 
strategies developed to overcome these; and specific strategies to increase walking were 
identified. Action and coping plans were made each week led by the participants, and during 
these consultations clinicians focused on helping participants to build self-efficacy, 
encouraging social support, providing disease specific education; participants were given the 
Living Well With COPD for PR booklet [28].  An outcome goal relating to an activity or 
function was also set at baseline, for example “To be able to walk to the centre of town on my 
own without fear.”  This was reviewed during the intervention; at consultation 6 and, if it was 
already met or participants felt it was too difficult  it was revised or amended. The outcome 
goal was then reviewed at the end to determine whether it was achieved. 
Pulmonary Rehabilitation  
PR was delivered by clinicians’ as per usual clinical practice. These programmes were 
delivered in either hospital or health centre outpatient departments. Participants attended a 
supervised exercise class twice a week for 6 weeks and were also given a booklet with 
exercises and encouraged to perform these independently on a third occasion. PR also 
consisted of centre based disease specific education, at which time participants could engage 
in discussion and ask questions.  Participants were also given the Living Well With COPD for 
PR booklet [28]. The exercise component usually lasted for one hour and PR sites reported 
that it generally consisted of cardiovascular exercises and lower and upper body strengthening 
exercises. A diary was used to record the exercises undertaken and the level of breathlessness 
measured with on Borg scale. Education sessions (30-60 minutes) were delivered at least once 
weekly.  
Data collection  
All screening, recruitment, adherence (number of sessions attended) and drop outs as well as 
the occurrence of adverse events were recorded, intervention adherence was set at 75% [29]. 
Demographics (gender, age, height, weight), medical and social details (living arrangements 
and employment status) and spirometry results were gathered  at the baseline assessment. 
Patients attended four study visits for outcome assessment: baseline assessment was 
conducted over two appointments 7 days apart (Visit 1 and 2). Participants were assessed 
again post-intervention (Visit 3) and at 3 months following the end of the intervention (Visit 
4). All data was collected by a trained independent assessor not involved in the delivery of 
intervention; a physiotherapist and/or a research assistant.   
 
The following outcome measures were collected from all participants: physical 
activity with the Actigraph® GT3X+ accelerometer [30] and a sealed Yamax Digiwalker 
CW700 [31] pedometer which were worn around the waist for seven days during all waking 
hours, as well as the long form of the International Physical Activity Questionnaire (IPAQ) 
[32]; exercise capacity with the Incremental Shuttle Walk Test (ISWT) [33]; health status 
with the COPD Assessment Test (CAT) [34] and EQ5D5L [35]; and a modified Global 
Rating of Change (GROC) Scale [36].  Participant stage of change [37] was assessed at 
baseline (Visit 1 and 2). 
Patient views  
Semi structured interviews were conducted post intervention (visit 3) with all available 
participants. The semi structured interview script is available in the e-supplement (eTable 4).  
Feasibility and fidelity of the PAI  
Participants in the PAI group set a weekly step goal. The step goal and the actual step 
count achieved by the participant were recorded and analysed to assess whether participants 
achieved their goal each week, and the degree of change. Additionally, an outcome goal was 
set at baseline, and at the post intervention assessment (visit 3) participants were asked to 
report the extent to which they met this goal on a visual analogue scale (0-10) with ten being 
“fully met”. The PAI was considered to be feasible based on whether participants could 
achieve their weekly step goal, achieve their overall outcome goal, and increase their step 
count across the intervention. 
 
Fidelity of the PAI was assessed using the checklist published by Borrelli (2011) [38]. 
This checklist was developed using the treatment fidelity framework provided by the National 
Institute of Health (NIH) Behavioral Change Consortium (BCC) [39] which includes five 
domains of treatment fidelity (Study Design, Training of providers, Delivery of treatment, 
Receipt of treatment, and Enactment of treatment skills). Under each of these domains, there 
are a number of items with which fidelity is assessed. Further details on the assessment of 
fidelity are available in the online supplement, eTable 2. 
Data analysis  
All participant screening and outcome measure data was entered into Statistical Package for 
Social Sciences (SPSS) version 22.0 (SPSS Inc., Chicago, IL). Data entry was independently 
assessed for accuracy and analysed per protocol. All continuous variables were checked for 
normal distribution using the Shapiro-Wilk Test, which confirmed that most of the data were 
normally distributed; BMI, FEV1% and FVC were not normally distributed. Descriptive 
statistics were used to summarise the screening, recruitment, adherence and population 
demographics. Only Actigraph data that contained a minimum of five days of ten hours wear 
time were used for analysis; and only sealed pedometer data that had a minimum of five days 
of 100-50,000 steps were used for analysis [40, 4]. As this was a feasibility study, we were 
not focused on statistical significance and therefore mean (standard deviation) (SD) 
difference, with 95% confidence interval (CI) was estimated at each follow-up time point for 
all outcome measures using paired t tests. Data is presented mean ([95% CI] or (SD)), and 
nominal data is presented as percentages.  
 
Qualitative data was analysed using Kings Template analysis [42]. A template of 
predefined themes was created using the semi structured interview schedule as guidance. The 
transcripts were analysed with the predefined themes, and subthemes were added to ensure all 
relevant text was being captured and coded. All transcripts were checked to ensure all relevant 
text had been coded according to the final template, and two researchers outside the team 
reviewed three transcripts each. 
 
All unsealed pedometer data relating to weekly step goals and steps achieved were 
recorded in Microsoft Excel 2010. Mean weekly step goals and mean weekly steps achieved 
were calculated and plotted graphically so as to demonstrate how these numbers tracked each 
other over time during the PAI. The mean difference between participants’ first and last 
recorded mean daily unsealed pedometer step count was also calculated.  Finally participants 
VAS scores for whether they felt they had achieved their outcome goal were also recorded 
and a mean score calculated.  
Results 
Participants  
Participant flow through the study is summarised in Figure 1. Six hundred and fifty one 
patients were screened between 4
th
 April 2014 and 27
th 
July 2015. Of those eligible 11% 
(n=50/453) were recruited over a 16 month period (see eTable 5 in the online supplement for 
full screening data).  N=50 participants with a mean (SD) age of 64.1(8.6), 24M and FEV1 1.4 
(0.6) L/min were recruited .   Patients were assessed and randomised to the PAI (n=24) or PR 
(n=26). One participant who was randomised to the PAI made a mistake and attended PR. 
Therefore n=27 attended PR and n=23 attended the PAI. A further n=1 participant  
randomised to PR was exlcuded from the analysis as subsequent information about their 
diagnosis revealed they did not meet the GOLD criteria for COPD [43]; therfore n=49 have 
been included in the analysis: n=23 PAI; n=26 PR. 
 
Patient characteristics are shown in Table 2. This group had complex needs; n=29 had 
more than two self-reported comorbidities and were prescribed multiple medications (mean 
(SD) 7.9 (3.8) which includes their specific respiratory medications). See the online 
supplement, eTable 6 for further details regarding participant characteristics. 
 
Intervention adherence 
There were 26% (n=6/23) drop outs/non-starters in the PAI group.  Reasons for not starting 
and drop outs are detailed in Figure 1. The PAI was adhered to (attended 75% sessions) by 
17/17 (100%) of those who did not drop out [29]. The time taken to compete the intervention 
was 12.4 weeks, ranging from 10.7 to 16.3 weeks and participants on average completed a 
mean (SD) 11.8 (0.6) of the 12 planned consultations.  
 There were 50% (n=13/26) drop outs/non-starters in the PR group. Reasons for not 
starting and drop outs are detailed in Figure 1. PR was adhered to (attended 75% sessions) by 
9/13 (70%) of those who did not drop out [29]. Participants who adhered to PR attended a 
mean (SD) of 10.5 (1.2) of the 12 planned classes.  
 
The numbers are too small to fully explore if there were any patterns in the 
characteristics of dropouts, although in both groups it does appear that those who dropped out 
were younger than completers: in the PAI dropouts had a mean (SD) age of 58.3 (8.9) years 
and completers 62.6 (7.6) years and in the PR group dropouts had a mean (SD) age of 65.2 
(8.1) years and completers 69.1 (7.3) years. 
 
Figure 1 also details the retention rates for participants providing post intervention 
(visit 3) and follow up (visit 4) outcome measures: post intervention n=18/23 (78.3%) (PAI) 
and n=19/26 (73.1%) (PR) and at follow up n=15/23 (65.2%) (PAI) and n=18/26 (69.2%) 
(PR). These numbers relate to participants providing at least one outcome measure. Some 
participants did not adhere to their intervention but returned for outcome measure assessment.  
Outcome measures  
A range of outcome measures were included in this study. The mean (SD) time taken in 
minutes to administer the study outcome measures across all four visits (3 time points) was 
under one hour per visit (59.9 (15.2) minutes).  The number of available outcome measures 
and reasons for missing data at each time point are available in eTable 7 in the online 
supplement.  
 Post intervention (visit 3) 
The mean (SD) daily step count as recorded by the Actigraph for the PAI group at baseline 
was 3305.6 (1960.2) steps for n=17 participants, and at post intervention was 4768.2 (2992.2) 
steps for n=14 participants; the mean difference (SD) [CI] was 972.0 (3230.3) [-1080.3 to 
3024.4], n=12. The mean (SD) daily step count as recorded by the Actigraph for the PR group 
at baseline was 3834.6 (2245.5) steps for n=23 participants and at post intervention was 
3476.6 (2307.9) steps for n=12 participants; the mean difference (SD) [CI] was 4.3 (662.7) [-
440.9 to 449.5], n=11. The mean (SD) moderate-vigorous physical activity (MVPA) in 
minutes as recorded by the Actigraph for the PAI at baseline was 14.3 (15.3) for n=17 
participants, and at post intervention was 24.4 (26.0) for n=14 participants; the mean 
difference (SD) [CI] was 6.6 (26.8) [-10.4 to 23.7] minutes, n=12. The mean (SD) MVPA in 
minutes as recorded by the Actigraph for the PR group at baseline was 13.9 (15.2) for n=23 
participants and at post intervention was 12.8 (20.0) for n= 12 participants; the mean 
difference (SD) [CI] was 0.9 (6.0) [-3.2 to 4.9] minutes, n=11. 
In relation to exercise capacity and quality of life; participants in the PAI had a mean (SD) 
distance of 253.0 (118.8) m at baseline, n=23 and 288.1 (107.0) m post intervention for n=16 
participants; the mean difference (SD) [CI] was -11.9 (90.4) [-60.1 to 36.3] m, n=16. 
Participants in the PR group had a mean (SD) distance of 259.2 (140.6) m on the ISWT at 
baseline, n=26 and 280 (139.7) m, n=17 post intervention; the mean difference (SD) [CI] was 
-7.6(69.9)     [-43.6 to 28.3] m, n=16. For the CAT score participants in the PAI had a mean 
score of 23.8(6.9) at baseline, n=23 and 22.5 (7.0) at post intervention, n= 17; the mean 
difference (SD) [CI] was 0.6 (7.7) [-3.3 to 4.6], n=17.  Participants in the PR group had a 
CAT score of 18.7 (7.3) at baseline for n=26 and a post intervention CAT score of 16.6 (5.3), 
n=19; the mean difference (SD) [CI] was -0.4 (6.4) [-3.5 to 2.7], n=19. The full baseline to 




Follow up at 3 months (visit 4)  
As recorded by the Actigraph there appears to be a general trend towards increasing step 
counts (mean (SD)) across the three time points in the PAI group: baseline step count 3305.6 
(1960.20, n17, post intervention step count 4768.2 (2992.1), n=18 and 5332.0 (3070.7) steps 
at follow up, n=15. In the PR group there was a decline in step count (mean (SD)) from 
baseline to post intervention, and then an increase at follow up: baseline step count 3946.2 
(2263.1), n=24, post intervention step count 3476.6 (2307.9), n=19, and a step count of 
4984.6 (3598.0) at follow up. 
Adverse events (AEs) 
There were 4 related and unexpected AEs; PAI (n=3): blister on the right heel and big toe, 
flare up of a knee swelling, reaction to nickel on pedometer due to a nickel allergy; and, PR (n 
=1): dizziness when leaving out patient department after an appointment.  These AEs were 
managed by providing advice to the participant for resolution, and no-one withdrew based in 
these AEs.   
Qualitative interviews 
N=32 participants were available to complete the semi structured interviews; n=16/23 
(69.6%) PAI; n=16/26 (61.5%) PR. Reasons for not being available for semi structured are 
detailed in the online supplement, eTable 4. Five core themes were identified: (i) Perceived 
benefits and impact of the PAI/PR on health, (ii) Views and satisfaction with content of 
PAI/PR, (iii) Adherence to the PAI/PR, (iv) Views about the outcome measures and (v) 
Views about continuing exercise. Participants in both groups enjoyed their respective 
programmes and experienced a range of benefits across their physical and mental health and 
also in terms of their social functioning. Participants were generally satisfied with their 
allocation; participants in the PAI felt the intervention was tailored specifically to them and 
the pedometer and step diary were well received. Participants in the PAI were generally 
satisfied with mix of phone and face to face contact. There were mixed views about the 
duration and frequency of contact; a small number in both the PAI and the PR group felt they 
could have engaged in the programme for longer, others in the PR group felt that twice 
weekly was too intense given they had other commitments. Adherence to the programmes 
were explored; participants in both groups encountered a number of barriers to participation 
including their health, weather, lack of social support as well as time and other commitments. 
Participants in PR also reported the group setting and a lack of motivation as barriers. 
However a number of facilitators were also recorded across the interviews including their 
own intrinsic motivation, social support and the staff. The pedometer and action and coping 
plan as well as developing their own strategies to overcome barriers were themed as 
facilitators for the PAI group. The group setting of PR was a facilitator for some. There were 
mixed views about the outcome measures; there were some participants who did not mind 
them, while others found them/parts of them burdensome. The majority of participants 
planned on continuing to engage in exercise/PA with specific plans including continuing to 
set goals and use the pedometer or join an exercise class. Participants in both groups were 
generally quite confident they would continue as the benefits achieved served as motivation.  
Feasibility and Fidelity of the PAI  
In relation to the achievement of weekly step goal, participants appeared to overachieve their 
step goals in the first week of the PAI, but as the intervention progressed the step goal and 
step count achieved aligned more closely (Figure 2). For those who provided step counts at 
two time points, most patients (n=17/20) demonstrated an increase in their step count 
following the PAI (Figure 3), n=13/20 met the MCID for step count (600-1100) [44]; step 
count recorded by the unsealed pedometer improved by a mean (SD) 2,087(2452) steps 
between week 1 and the last step count recorded. Following the PAI, participants rated 
whether they had met their outcome goal set out at the start of the intervention using the VAS 
scale (0=not met at all, 10=fully met). VAS scores were available for n=16/18; n=1 was 
unwell and did not travel for outcome measure collection and n=1 could not remember their 
outcome goal. Overall these participants reported achieving their outcome goal; mean (SD) 
8.8 (2.9). 
Results were obtained from the assessment of fidelity for the five domains of 
treatment fidelity i.e. (i) Study design: all items under this domain were met except for one 
(5/6 items were met). (ii) Training of providers: all items under the domain about training of 
providers were met. (iii) Delivery: a proportion of consultations n=36/221 (16%) were 
assessed and in this sample the majority of the components were delivered as intended 
(n=43/50). (iv) Receipt and (v) Enactment domains focus on the participants.  For receipt 
most items were fully received with only a few (n=3/18) items received on <100% of 
occasions. For enactment a few (n=2/6) items were not fully enacted. Further details on the 
results of fidelity of the PAI are available in the online supplement, eTable 4 
 
Discussion 
This feasibility study demonstrates key considerations for conducting a future trial of a PAI 
versus PR in COPD. The applicable NIHR criteria for the success of a feasibility trial were 
met and based on the results of this study, including the qualitative data, a future trial is 
feasible. The PAI was effective for increasing step count, feasible to deliver and had good 
fidelity.  However, before proceeding to larger trial strategies for increasing recruitment, 
reducing dropouts, improving adherence, and for optimising the efficiency of data collection 
would need to be considered. 
 
Recruitment to this study was generally feasible; we planned to recruit over a period of 14 
months and achieved our target number at 16 months. Our recruitment process for this 
feasibility study was uniquely influenced by opportunities for easy access to programmes 
within limited study resources; we confined the study to two HSC Trusts and we recruited 
11% of those eligible. Recruitment rates can vary across the COPD literature. For example, 
recruitment rates of 3.9% (103/2646) in a recent study exploring the feasibility of 
conventional PR versus a web based PR [45] and 63.3% 57/90 in a cohort study on PR in 
COPD [28] have been reported. In research on PAIs in COPD, 18.1% (140/775) were 
recruited in a study exploring the effects of a short-term (3 months) and a long-term (18 
months) exercise program on self-reported disability and physical function in COPD [46] and 
89.8% (71/79) in a study exploring the effects of supervised high intensity continuous or 
interval training with unsupervised self-paced training [47].  A large number of patients 
referred to the PR clinics proved  not to be suitable for this study due to e.g. musculoskeletal 
problems, vascular problems, cardiac issues (198/601, 33%); our criteria helped us to identify 
these patients and triage their care to an appropriate service, test or procedure prior to further 
assessment for PR. Not all patients referred for PR were interested in taking part (n=131/601, 
22%), and a small number (44/601, 7%) had COPD but this was not the primary diagnosis 
and were therefore excluded.    This study provides data to estimate the number of sites that 
would be needed for a larger trial; the estimated sample size for full scale trial is 150 (75 per 
group) to allow us to detect a 1500 steps between group difference with 80% power, taking 
into account the current minimally clinical important difference for this population [44]. 
Alternative trial designs could also be considered, for example a non-inferiority trial design or 
a preference randomised controlled trial [48, 49]. Broader inclusion criteria, as well as more 
PR sites, could improve the recruitment rates. To achieve recruitment targets for a larger trial 
we would need to explore the capacity for recruitment at each PR site. 
 
The dropout for the PAI (26%) was lower than the dropout in PR (50%). Although 
patients who dropped out were younger than completers this pattern and other differences in 
important characteristics between dropouts and completers would need to be explored in a 
larger data set.  A number of participants in the current study also dropped out of PR for 
health reasons, patients with COPD can experience frequent exacerbations and often present 
with a number of comorbidities [5]. There were other patient reported barriers to participation 
in the PR group that had the potential to be overcome in the PAI; the individualised and 
flexible nature of the PAI as well the opportunity for phone contact could have facilitated 
participation for participants who did not enjoy the PR group setting, had transport difficulties 
or were restricted due to other commitments. The qualitative component further explored 
barriers to adherence; the results indicate a need for a more personalised approach and 
stronger emphasis on identifying each individual’s facilitators to help promote adherence. 
Furthermore the dropout rate for PR (50%) was higher than that reported (29%) in a recent PR 
audit conducted in England and Wales [5]. Reasons for this higher rate of dropout are unclear, 
and previous studies in PR in the Northern Ireland COPD population have reported dropout 
rates which are more consistent with the rest of the UK (between about 10%- 28%) [28, 50]; 
therefore, dropout rates from PR could possibly be reduced through the implementation of 
quality assurance measures prior to a future study. 
A high number of participants did not meet the wear time criteria for the Actigraph 
[40]. A future trial could consider less stringent wear time rules to optimise data or consider a 
utilising a different monitor. The qualitative research findings indicated that a small number 
of people found the belt uncomfortable and at times cumbersome. Even though this was a 
small number of people, in a study with such a small sample size any loss of data will affect 
the overall outcome. Although the Actigraph GT3X is considered one of the most valid 
activity monitors for measuring physical activity in people with COPD [51], a future trial 
should explore with patients where they are most likely to wear an activity monitor e.g. wrist, 
thigh, ankle, or waist. Popular activity monitors such as the Fitbit have been validated in 
people with COPD and could be considered in a future trial to maximise physical activity data 
[52].  Finally step count was also assessed with a pedometer which was sealed (to hide the 
step count data) at baseline and again post intervention. There were discrepancies between the 
Actigraph step count data and pedometer data. Current evidence indicates that these two 
devices are not interchangeable [53, 54, 55]. The Actigraph is a more precise measure of 
physical activity and so it may be more suitable for data collection as an outcome measure for 
research [53]. The pedometer (unsealed) however did appear to be a feasible tool for setting 
and monitoring step counts during the PAI and it provided good motivation to participants. 
 
The PAI appears to be safe to deliver; with few and minor adverse events. Recording 
of achievement of weekly step goals as an indication of feasibility has been reported in other 
studies [56]. Throughout the intervention the step goals and actual steps achieved were 
closely matched with most participants achieving their goal each week similar to other studies 
in clinical populations [9].  The greatest improvement was observed in the first week with 
smaller, more gradual improvements over time; perhaps just wearing the monitor in the first 
week provided an initial motivation. The pedometer data obtained from participants during 
the PAI demonstrated (for those who recorded step counts at two time points) a mean increase 
(2,087) almost double that of the upper end of the minimally clinically important difference 
(MCID) for step count in the COPD population (600-1100) [44]. Furthermore, based on the 
Actigraph data the MVPA also increased, albeit there is not MCID available for MVPA in 
COPD. Thereby indicating the potential efficacy of this intervention and potential for use in a 
future trial. Patient selection for such interventions may be important. A recent multicentre 
randomized controlled study reported that patients more likely to respond to physical activity 
coaching interventions were those patients with better preserved functional capacity [57]. 
Some of our patient population were perhaps too frail to benefit maximally from the proposed 
PAI.   
Furthermore, the assessment of fidelity demonstrated that the intervention was 
delivered as planned. Overall fidelity was good but an improvement could be to ensure that all 
providers are certified to deliver the intervention, and to assess fidelity regularly throughout 
the intervention, not at the end as in the present trial. Additionally, our assessment of delivery 
only sought to assess whether a component was delivered or not, and a scale assessing the 
quality of delivery of each component could further demonstrate how well the intervention 
was delivered. The fidelity assessment methods and results will be reported in a future 
publication.  
The estimated time to deliver the PAI to eight patients individually across 12 weeks is 
60.8 (34.4) hours. The estimated time to deliver a PR programme to eight patients in a group 
over 6 weeks is 24 hours. The LIVELY PAI appears to takes approximately double the 
amount of time to deliver to eight patients compared to PR, which would result in increased 
costs. However, there is a large SD in the predicted length of time to deliver the PAI to eight 
patients, and the PAI had a higher rate of adherence which has potential for cost saving 
implications in the longer term. Finally, we are comparing two different models of treatment 
for people with COPD and there are opportunities to modify the PAI to reduce costs and bring 
them more in line with PR.  For example, using an online platform linked to the activity 
monitor whereby the steps are automatically uploaded, so that the interventionist can review 
these before the consultation, would reduce costs. The number of face to face consultations 
could also be decreased; qualitative data from the current trial demonstrated that some 
participants felt they could have transitioned to this earlier. It has been suggested that much of 
the coaching could be done using a telemedicine approach [57, 58], although not all trials 
were equally successful [59].   Furthermore delivery in a group setting while retaining 
individual setting of step goals could decrease the time taken to deliver the PAI, delivery of 
education in a group setting could also be adopted in a future trial. The PAI in this study 
included management of breathlessness, and advice regarding inhalers and the management of 
an exacerbation.  Patients were also given the LWWCOPD for PR booklet which includes 
information on the same education topics that are delivered in PR, Additional education and 
other components could be embedded in a future trial for example, additional education topics 
could be added to mirror those included in PR, and/or patients could attend group education 
sessions.  
The underpinning rationale for this study was that PR may not be suitable for all 
patients with COPD; this may also be true for the PAI, as evidenced by the large standard 
deviation in step count and MVPA for both groups. Figure 3 also demonstrates that some 
participants in the PAI were more responsive to this intervention that others. These results 
suggest that there are patient phenotypes which may be more responsive to a PAI or to PR. 
The population in the current study were of moderate disease severity and according to the 
CAT scores, their COPD had a severe impact on their quality of life.  Characteristics such as 
disease severity have been reported to have an impact on daily physical activity levels [60] 
and patients with better preserved functional status are reported to have had better outcomes 
in a remote telecoaching PAI [57]. Furthermore patient preferences for the type of activity 
may also have an impact on outcome for example the results of the qualitative component of 
the current study found that the group setting was a both a facilitator and barrier for 
participants in the PR group. Booth et al. [61] reported that individuals have clear preferences 
for the types of activity they wish to engage in. Therefore, patient selection in terms of disease 
severity, functional status and individual preference may be important to consider in a future 
trial. Further research is required to establish phenotypes and preferences to better stratify 
patient care and optimise outcome.  
 
Strengths and limitations 
A key strength of this study is that it provides important feasibility data regarding 
screening, recruitment, delivery of the intervention and data analysis for a future trial. The PR 
was delivered as part of usual care. The results of the PR group in relation to exercise capacity 
and quality of life are not in line with expected outcomes [1] and may in part be explained by 
the proportion of non adherherers/dropouts in this group.; a future trial should consider 
ensuring all PR programmes are optimised prior to study implementation through to study 
completion and quality assurance measures for PR should be included as part of usual care.  
A future trial would also need to include a cost effectiveness limb as well as additional 
data beyond the EQ5D5L to allow for a full health economic appraisal. Furthermore in the 
current intervention the measurement of step count alone as an indicator of physical activity, 
although central to a number of tasks does, not take into account all the components necessary 




All applicable NIHR criteria for the success of a feasibility study were met with important 
learning and information regarding recruitment, eligibility, outcome measures and the sample 
size for a future study identified. The mixed methods design has enriched the data and 
exploring patients’ views and satisfaction has helped complement and verify the quantitative 
findings.  The LIVELY PAI appears to be effective in improving step counts in people with 
COPD, feasible to deliver and had good fidelity. This study provides key information to 
inform a future randomised controlled trial in physical activity. 
 
Acknowledgments  
The study was funded by the Northern Ireland Chest Heart and Stroke (NICHS). PhD student (O’Shea 
O), was funded by the Department of Employment and Learning. The study was sponsored by the 
Ulster University and the Western and Belfast Health and Social Care Trusts. The study was supported 
by the Northern Ireland Clinical Research Network (NICRN) Respiratory Health interest group, thank 
you specifically to Dr Denise Cosgrove, Adrian McDonald and Dr. Catherine Hanratty. Thank you to 
our patient representative (JH) for their valuable input to the study 
 
Declaration of interest 
The authors have no conflicts of interest to declare. 
References  
1.McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary 
rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Syst 
Rev 2015; 2:1-173. 
2.Troosters T, Gosselink R, Janssens W, Decramer M. Exercise training and pulmonary 
rehabilitation: New insights and remaining challenges. Eur Respir Rev 2010; 
19(115):24–29. 
3. Watz H, Pitta F, Rochester CL, Garcia-Aymerich J, ZuWallack R, Troosters T, et al. An 
official European Respiratory Society statement on physical activity in COPD. Eur 
Respir J. 2014; 44(6):1521–37. 
4. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R et al. British 
Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE. 
Thorax 2013 Sep; 68(Suppl 2):ii1–ii30. 
5. Steiner MC, Roberts MC, Lowe D, Welham S, Searle L, Skipper E et al. National Chronic 
Obstructive Pulmonary Disease (COPD) Audit Programme: Clinical audit of 
Pulmonary Rehabilitation services in England and Wales 2015. Healthcare Quality 
Improvement Partnership. 2016. 
6. Jones SE, Green SA, Clark AL, Dickson MJ, Nolan AM, Moloney C et al. Pulmonary 
rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, 
uptake and adherence. Thorax. 2014; 69: 181–2. 
7. Rochester CL, Vogiatzis I, Holland AE, Lareau SC, Marciniuk DD, Puhan MA et al. Am J 
Respir Crit Care Med. 2015; 192 (11): 1373–1386. 
8. Min-Lee I and Skerrett PJ. Physical activity and all-cause mortality: what is the dose-
response relation? Med. Sci. Sports Exerc. 2001; 33(6): S459–S471. 
9. McDonough SM, A. Tully MA, Boyd A, O’Connor SR, Kerr DP, O’Neill SM, et al.  
  Pedometer-driven Walking for Chronic Low Back Pain A Feasibility Randomized 
Controlled Trial. Clin J Pain. 2013; 29(11): 972–981. 
10. Wilson JJ, O’Neill B, Collins EG Bradley J. Interventions to Increase Physical Activity in 
Patients with COPD: A Comprehensive Review. COPD 2014: 00:1-12.  
11.  Behnke M, Wewel AR, Kirsten D, Joreres, RA, Magnussen, H. Exercise training raises 
daily activity in stronger than predicted from exercise capacity in patients with COPD. 
Resp Med. 2005; 99(6):711-717.  
12. Breyer M, Breyer-Kohansal R, Funk G, Dornhofer N, Spruit MA, Wouters EF, et al. 
Nordic Walking improves daily physical activities in COPD: a randomised controlled 
trial. Resp Res. 2010; 11 (112). 
13. Moy ML, Janney AW, Nguyen  HQ, Matthess KR, Cohen M, Garshick E, et al.  Use of 
pedometer and Internet-mediated walking program inpatients with chronic obstructive 
pulmonary disease. J Rehabil Res Dev. 2010; 47(5): 485–496. 
14. Hospes G, Bossenbroek L, ten Hacken NH, van Hengel P, de Greef MH. Enhancement of 
daily physical activity increases physical fi tness of outclinic COPD patients: results of 
an exercise counseling program. Patient Educ Couns 2009; 75(2):274–278. 
15. Altenburg WA, ten Hacken NH, Bossenbroek L, Kerstjens HA, de Greef MH, Wempe JB. 
Short- and long-term effects of a physical activity counselling programme in COPD: a 
randomized controlled trial. Respir Med. 2015; 109(1):112-21. 
16. Tabak M, Vollenbroek-Hutten MM, van der Valk PD, van der Palen J, Hermens HJ. A 
telerehabilitation intervention for patients with Chronic Obstructive Pulmonary 
Disease: a randomized controlled pilot trial. Clin Rehabil 2013; 28(6):582–591. 
17. Steele BG, Belza B, Cain KC, Coppersmith J, Lakshminarayan S, Howard J, Haselkorn 
JK. A randomized clinical trial of an activity and exercise adherence intervention in 
chronic pulmonary disease. Arch Phys Med Rehabil. 2008; 89(3):404–412. 
18. National Institute for Health Research Success Criteria for a feasibility trial [internet]. 
Cited 2017 May 5. Available from: http://www.nets.nihr.ac.uk/glossary  
19. Craig P, Dieppe P, MacIntyre S, Michie S, Nazareth I, Petticrew M. Medical Research 
Councol [internet]. 2006 [Cited 2017 May 20] Developing and evaluating complex 
interventions: new guidance. Available from: 
www.mrc.ac.uk/complexinterventionsguidance 
20. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP et al. A tutorial on pilot studies: the 
what, why and how. BMC Med Res Method 2010; 10:1.  
21. Lancaster G. Pilot and feasibility studies come of age! Pilot Feasibility Stud 2015; 1:1.  
22. O’Cathain A, Hoddinott P, Lewin S, Thomas KJ, Young B, Adamson J et al.Maximising 
the impact of qualitative research in feasibility studies for randomised controlled 
trials: guidance for researchers. Pilot  Feasibility Stud 2015; 1:32. 
23. Hoffman TC, Glasziou PP, Milne R, Moher D, Altman DG, Barbour V et al. Better 
reporting of interventions: template for intervention description and replication 
(TIDieR) checklist and guide. BMJ 2014; 348:1687. 
24. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: 
updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 
2010;152:726–32. 
25. Sim J and Lewis M. The size of a pilot study for a clinical trial should be calculated in 
relation to considerations of precision and efficiency. J Clin Epidemiol 2012; 65:301-
308. 
26. Michie S, Atkins L, West R. The Behaviour Change Wheel: A Guide to Designing 
Interventions, First Edition. Silverback Publishing, Great Britain. 2014. 
27. Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, Eccles MP, 
Cane J, Wood CE. The behavior change technique Taxonomy (v1) of 93 
Hierarchically clustered techniques: Building an international consensus for the 
reporting of behavior change interventions. Ann  Behav Med 2013; 46:81–95. 
28. Cosgrove D, MacMahon J, Bourbeau J, Bradley JM, O'Neill B. Facilitating education in 
pulmonary rehabilitation using the living well with COPD programme for pulmonary 
rehabilitation: a process evaluation. BMC Pulm Med. 2013;13:50. 
29. Williams S, Baxter N, Buxton M,  Harrison A, Holmes S, Hughes E et al. IMPRESS 
Guide to Pulmonary Rehabilitation British Thoracic Society Reports. 2011; 3(2). 
30. Rabinovich RA, Louvaris Z, Raste Y,  Langer D, Van Remoortel H, Giavedoni S,et al. 
Validity of physical activity monitors during daily life in patients with COPD. Eur 
Respir J. 2013; 42(5):1205-15. 
31. Schneider PL, Crouter S, Basset DR. Pedometer measures of free living physical activity: 
comparison of 13 models.  Med  Sci Sports  Exerc. 2004; 36(2):331-5. 
32. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al. 
International Physical Activity Questionnaire:12-Country Reliability and Validity. 
Med Sci Sports Exerc. 2003; 35(8):1381-95. 
33. Singh SJ, Morgan MDL, A.E. Hardman AE, Rowe C, Bardsley PA. Comparison of 
oxygen uptake during a conventional treadmill test and the shuttle walking test in 
chronic airflow limitation. Eur Respir J. 1994; 7: 2016–2020. 
34. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and 
first validation of the COPD Assessment Test. Eur Respir J 2009;34:648–654. 
35. Briggs AH, Glick HA, Lozano-Ortega G, Spencer M, Calverley PMA, 
Jonese PW et al. Is treatment with ICS and LABA cost-effective for COPD? 
Multinational economic analysis of the TORCH study. Eur Respir J 2010; 35: 532–
539. 
36. Perry M. Activity Monitoring and low back pain. Chapter 1.  Awarded PhD 2010 from 
University of Otago. 
37. Marcus BH and Forsyth LH. Motivating people to be physically active. 2
nd
 edition. 
Human Kinetics: United States of America; 2009. 
38. Borrelli B. The Assessment, Monitoring, and Enhancement of Treatment Fidelity in 
Public Health Clinical Trails. J Public Health Dent. 2011;71 (1): 1-21. 
39. Bellg A, Borrelli B, Resnick B, Hecht J, Minicucci D, Ory M, et al. Enhancing treatment 
fidelity in health behavior change studies: best practices and recommendations from 
the NIH Behavior Change Consortium. Health Psychol. 2004; 23:443–51. 
40. Byron B and Rowe DA. Measuring free-living physical activity in COPD patients: 
Deriving methodology standards for clinical trials through a review of research 
studies. Contemp Clin Trials. 2016; 47:172–184. 
41. Matthiessen J, Raustorp A, Knudson V. Reduction in pedometer-determined physical 
activity in the adult Danish population from 2007 to 2012. Scand J Public Health 
2015; 1–9. 
42. King, N. Template analysis’, in G.Symon and C.Cassell (eds.) Qualitative Methods and  
Analysis in Organizational Research. London: Sage. 1998 
43. GOLD [internet] Cited 2017 April 04. Available from: http://goldcopd.org/wp-
content/uploads/2016/12/wms-GOLD-2017-Pocket-Guide.pdf 
44. Demeyer H, Burtin C, Hornikx M, Camillo CA, Van Remoortel H, Langer D et al. The 
Minimal Important Difference in Physical Activity in Patients with COPD. PLoS ONE 
2016; 11(4):1-11. 
45. Chaplin E, Hewitt S, Apps L, Bankart J, Pulikottil-Jacob R, Boyce S et al. Interactive 
web-based pulmonary rehabilitation programme: a randomised controlled feasibility 
trial. BMJ Open 2017;7:e013682. 
46. Varga J, Porszasz  J, Boda K, Richard Casaburi R, Somfay A. Supervised high intensity 
continuous and interval training vs. self-paced training in COPD. Respir Med 2007; 
101: 2297–2304. 
47. Berry MJ, Rejeski WJ,. Adair NE, Ettinger WH, Zaccaro DJ, Sevick MA. A Randomized, 
Controlled Trial Comparing Long-term and Short-term Exercise in Patients With 
Chronic Obstructive Pulmonary Disease. J Cardiopulm Rehabil 2003;23:60-68. 
48. Horton EJ, Mitchell KE, Johnson-Warrington V, Apps LD, Sewell L, Morgan M et al. 
Comparison of a structured home-based rehabilitation programme with conventional 
supervised pulmonary rehabilitation: a randomised non-inferiority trial. Thorax 
2017;0:1–8 
49. Main E. Airway clearance research in CF: the ‘perfect storm’ of strong preference and 
effortful participation in long-term, non-blinded studies. Thorax 2013;68:701–702 
50. O’Neill B, McKevitt AM, Sara Rafferty S, Bradley JM,  Johnston D, Bradbury I et al. A 
Comparison of Twice- Versus Once-Weekly Supervision During Pulmonary 
Rehabilitation in Chronic Obstructive Pulmonary Disease. Arch Phys Med Rehabil. 
2008; 88. 
51. van Remoortel H, Raste Y., Louvaris Z, Giavedoni S, Burtin C, Langer D. Validity of Six 
Activity Monitors in Chronic Obstructive Pulmonary Disease: A Comparison with 
Indirect Calorimetry. PLoS ONE 2012;7(6) e39198. 
52.Vooijs M, Alpay  LA,  Snoeck-Stroband JB, Beerthuizen T, Siemonsma P, Abbink JJ, 
Validity and Usability of Low-Cost Accelerometers for Internet-Based Self-
Monitoring of Physical Activity in Patients With Chronic Obstructive Pulmonary 
Disease. Interact J Med Res 2014; 3(4):e14. 
53. O’Neill B, McDonough SM, Wilson JJ, Bradbury I, Hayes K, Kirk A. Comparing 
accelerometer, pedometer and a questionnaire for measuring physical activity in 
bronchiectasis: a validity and feasibility study? Respir Res 2017;18:16.  
54. Kinnunen TI, Tennant PWG, McParlin C, Poston L, Robson SC, Bell R. Agreement 
between pedometer and accelerometer in measuring physical activity in overweight 
and obese pregnant women. BMC Public Health. 2011;11:501. doi:10.1186/1471-
2458-11-501. 
55. Harris TJ, Owen CG, Victor CR, Adams R, Ekelund U, Cook DG. A comparison of 
questionnaire, accelerometer, and pedometer: measures in older people. Med Sci 
Sports Exerc. 2009;41:1392–402. 
56. Paxton RJ, Forster JE, Miller MJ, Gerron KL, Stevens-Lapsley JE, Christiansen CL. A 
feasibility study for improved physical activity after total knee arthroplasty. J Ageing 
Phys Act 2017; 0 (0): 1-21.  
57. Demeyer H, Louvaris Z, Frei A, Rabinovich RA, de Jong C,  Gimeno-Santos E, et al. 
Physical activity is increased by a 12-week semiautomated telecoaching programme in 
patients with COPD: a multicentre randomised controlled trial. Thorax 2017;72:415–
423. 
58. Moy ML, Collins  RJ, Martinez  CH, Kadri  R, Roman P, Holleman RG, et al. An 
Internet-Mediated Pedometer-Based Program Improves Health-Related Quality-of-
Life Domains and Daily Step Counts in COPD A Randomized Controlled Trial. Chest 
2015; 148(1): 128 – 137 
59. Vorrink SNW, Kort HSM, Troosters T, Zanen P and Lammers JWJ.  Efficacy of an 
mHealth intervention to stimulate physical activity in COPD patients after pulmonary 
rehabilitation.  Eur Respir J 2016; 48: 1019–102 
60. Clarenbach CF, Sievi NA, Haile SR, Brack T, Brutsche MH, Fewy M, et al. Determinants of 
annual change in physical activity in COPD. Respirology 2017 doi: 10.1111/resp.13035 
61. Booth ML, Bauman A, Owen N, Gore CJ. Physical Activity Preferences, Preferred 
Sources of Assistance, and Perceived Barriers to Increased Activity among Physically 






Table 1 National Institute for Health Research Success Criteria for a feasibility trial* 
Criteria Present Comment 
Number of eligible patients.         See Table 2. 
Willingness of participants to be randomised.  Yes all patients were willing to be 
randomised; one participant attended 
the incorrect allocation. 
Willingness of clinicians to recruit participants.  See Table 2. 
Characteristics of the proposed outcome measure.          This has been reported. 
Time needed to collect and analyse data.  
 
This has been reported in the main 
paper. 






Table 2 and figure 1 in the main 
paper details these. 
Standard deviation of the outcome measure, which 
is needed in some cases to estimate sample size. 
 
 
Measures of variance reported 
*relevant criteria only for this study included 
  
Table 2 Baseline demographics and characteristics of participants 
*Not meeting criteria (Actigraph: 5 days of ten hours wear time, pedometer: 100-50,000 steps 












Age (years)   
Mean (±SD) 
64.4 (8.6) 61.1 (8.5) 67.2 (7.8) 
Gender (M:F) 24:25 13:10 11:15 





















































































































Figure 1 CONSORT Flow of participants through the study and adherence to the PAI and PR [24] * 
reasons for exclusion are in eTable 5 **Adherence set at 75% (attending 9/12 classes/consultations) 
[22], ***LTF Lost to follow up 
 
PAI (N=23) 
-Adhered to intervention** n=17 
-Did not start n=1 (other 
commitments) 
-Drop out n=5 (n=1 exacerbation, 
n=1 other health issues, n=1 other 
commitments, n=1 felt it did not 
suit them, n=1 withdrew consent) 
Assessed for eligibility (N=651) 
 Excluded (601)* 
 Not meeting criteria (n=198) 
 Declined to participate (n=215) 
 Other (n= 186) 
 Not reported (n=2) 
Randomised (N=50) 
Allocated to PAI n=24 
Baseline Assessment n=26  
Did not meet GOLD diagnostic for COPD n=1 
 
Post intervention (visit 3) 
Retained n= 19 
Withdrawal n=2 
LTF** n=5 
       
 
Baseline Assessment n= 24 
Met GOLD diagnostic criteria for COPD n=24 
 
Follow up (visit 4) 




Post intervention (visit 3) 




Follow up (visit 4) 
Retained n=15 
 Withdrawal n=8 
LTF** n=0 
Received allocation n=25 
Attended this group in error n=1 
 
Enrolment 
Allocated to PR n=26 
Received allocation n=23 
Attended PR in error n=1 
Allocation 
PR (n=26) 
-Adhered to intervention** n=9 
-Attended <9 classes n=4 
-Did not start n=5 (n=1 
exacerbation, n=2 LTF*** n=1 
family issues, n= 1 perceived there 
to be too many women in the 
waiting room) 
-Drop out n=8 (n=1 work, n=2 
exacerbation, n=2 other health 
issues, n=2 lack of enjoyment, n=1 
transport issues) 
 Figure 2 Mean daily step count goal compared to the step count achieved across the 
12 PAI [numbers of participants providing step count data at each time point varies 
due to attendance and withdrawals; familiarisation. Week 1, n=21; Week 2, n=18W 
week 3, n=19; Week 4, n=18; Week 5, n=17; Week 6, n=18; Week 7, n=18; Week 8, 



























 Figure 3 Difference between the mean daily step count for the familiarisation week and last 
mean daily step count available step count recorded with unsealed pedometer for all 















 E supplement  
On line E Suppl Contents 
 eTable 1 TIDieR checklist [16]: Assessment of reporting in the LIVELY 
COPD project 
 eTable 2 The assessment and results of treatment fidelity in the LIVELY 
COPD project with the Borrelli (2011) checklist 
 eTable 3 Examples of how weekly step goals were set and of outcome goals 
 eTable 4 Summary of semi structured interview schedule 
 eTable 5 Screening data, reasons for exclusion from the LIVELY COPD 
project. 
 eTable 6 Baseline demographics and characteristics of participants. 
 eTable 7 Available outcome measures at each time point and reasons for any 
missing data. 
 eTable 8 Participant physical activity outcomes (Actigraph, sealed pedometer, 
IPAQ and GROC), ISWT, CAT and EQ5D5L for the PAI group and PR group 









 TIDieR Checklist Reported 
1.Brief name: provide a name or a phrase that describes the intervention  
2.Why: Describe any rationale theory or goal of elements essential to the 
intervention 
 
3. What (materials): describe any physical or informational materials used 
in the intervention including those provided to participants or used in the 
intervention or in training of intervention providers. Provide information 
on where the materials can be accessed*. 
 
4. What (procedures): describe each of the procedures, activities and or 
processes used in the intervention including any enabling or support 
activities. 
 
5. Who provided: for each category of intervention provider, describe 
their expertise background and specific training given. 
 
6. How: Describe the modes of delivery such as face to face or by some 
other mechanism, such as internet/telephone) of the intervention and 
whether it was provided individually or in a group. 
 
7. Where: Describe the type(s) of location(s) where the intervention 
occurred including any necessary infrastructure or relevant features 
 
8. When and how much: Describe the number of times the intervention 
was delivered and over what period of time including the number of 
sessions, their schedule and their duration, intensity and dose 
 
9. Tailoring: If the intervention was planned to be personalised, titrated or 
adapted then describe what, why when and how 
  
10. Modifications: If the intervention was modified during the course of N/A 
eTable 1  TIDieR checklist (16): Assessment of reporting in the LIVELY COPD project 
 


















the study describe the changes (What, why, when and how) 
11. How well (planned): if the intervention adherence or fidelity was 
assessed, describe how and by whom and if any strategies were used to 
maintain or improve fidelity describe them. 
 
12. How well (actual): If the intervention adherence or fidelity was 
















-The PAI was planned to take 12 weeks; delivery over 14 weeks was allowed to 
accommodate for missed consultations.  The face to face consultations were planned 
to take up to one hour with telephone consultations to take 10-20 minutes.  
-PR sites were contacted prior to the intervention starting, and mid way through the 
study to ensure they were still adhering to the BTS guidelines (4) i.e. twice weekly 
sessions for 6 weeks.  
-Specific provider credentials were set out from the beginning; any nurses or 
physiotherapists working in the Northern Irish Clinical Research who had 
experience with respiratory patients were sought. Three providers (2 
physiotherapists and 1 nurse) were trained to deliver the intervention. 
-The LIVELY intervention was based upon recommendations from the current 
physical activity guidelines, influences from the stages of changes and the COM-B 
model was considered.  The study team had expert knowledge in research, 
behaviour change, COPD and physical activity. The measures used to assess the 
efficacy of the PAI in comparison to PR were chosen as they reflected the 
hypothesis and the mechanisms of action of the intervention. 
eTable 2  The assessment and results of treatment fidelity in the LIVELY COPD project with the 
Borrelli (2011) checklist 
-Multiple providers were trained to deliver the intervention; participants were 






-A plan for training was set out; the first three and fifth training sessions were 
conducted as planned, training day 4 was conducted 2 months early, as due to study 
through put additional training was required early. It was planned that all providers 
would receive the standard training; due to unforeseen circumstances one provider 
could not attend all training days; but received one-one training to compensate for 
these missed days. 
-Skill acquisition was assessed informally during the training using case studies. 
Regular training and a mentorship programme ensured there was no drift in skill. 
For the mentorship programme providers had contact with an experienced member 
of the research team before and after each consultation. 
-The training included theory, practical components, case scenarios, and group work 
to help support different training needs. A feedback questionnaire was completed by 
the providers at approximately midway to assess if they felt the training took into 






-The mentorship programme helped to ensure that the content dose was delivered as 
specified. Pre consultation checklists and templates for documentation also helped 
to ensure this. The time taken to complete the intervention was 12.4 weeks, 
participants completed a mean (SD) 11.8 (0.6) of the 12 planned consultations. The 
face to face consultations lasted a mean (SD) of 49.8 (8.8) minutes and telephone 
consultations lasted 19.5 (SD 2.8) minutes. 
-N=80/221 consultations (36.2%) were recorded; delivery was assessed in n=36 
(16.3%) consultations. Specific checklists were developed to assess delivery for the 
LIVELY PAI, this checklist contained 50 items. In line with current guidelines good 
fidelity was set at 80%; n=43/50 items were delivered with good fidelity. 
-A treatment manual was designed specifically for the LIVELY PAI containing step diary 






-The LIVELY study documents were reviewed to assess how the items on the 
Borrelli checklist (2011) were being met in the context of LIVELY and a checklist 
developed. N=18 strategies items for receipt were identified. 
-16.3% of consultations were assessed for receipt. N=3/18 items on the receipt 




-The LIVELY study documents were reviewed to assess how the items on the 
Borrelli checklist (2011) could be assessed in the context of the LIVELY PAI. Six 
items under enactment were identified. 
-16.3% of consultations were assessed for enactment. N=2/6 items on the enactment 
checklist were not enacted on 100% of the time. 
eTable 2 Examples of how weekly step goal was set 
 
Examples of how the weekly step goal was set  
Example 1 
Total weekly step count for 7days from previous week 
19,747 
 
Average daily steps from previous week 
2,821 
 
Self-efficacy walk result  
1,027 
 
Agreed step goal  
4,300 on 7/7 days 
Example 2 
Total weekly step count for 7days from previous week 
39,935 
 
Average daily steps from previous week 
5,705 
 
Self-efficacy walk result  
992 
 
Agreed step goal  
8,000 on 5/7 days 
The step target for each subsequent week was agreed between the physiotherapist/nurse and the 
participant by referring to 1) current walking behaviour identified from the mean daily step count 
for the previous week calculated from the pedometer steps/walking diary, and 2) the number of 
steps accumulated during the 10-minute ‘self-efficacy walk’.  The consultations included 
discussion of current physical activity behaviour, the identification of barriers and facilitators to 
change, strategies to enable patients to meet walking goals and address barriers, and strategies to 
enhance confidence/self-efficacy around achieving goals (self-efficacy, goal setting), action and 
























credible sources, and maintenance and preventing relapse.  Each step goal was individual to the 
participant and fully personalised to them. 
eTable 4 Summary of semi structured interview schedule 
Interview Schedule Questions  
How do you feel the PAI/ PRprogramme has affected your health?  
Do you think your relatives/carers/friends see a difference in you? 
Do you think you have a good understanding of the benefits of exercise/PA for someone with 
COPD? 
How satisfied were you with the: 
a. face-to-face physical activity intervention? 
b.pulmonary rehabilitation programme? 
What suggestions if any, would you give to improve the PAI/ PR programme? 
How involved did you feel in shaping the PAI/ PR programme, do you feel your level of 
fitness/ability was considered? 
How easy did you find it to adhere to the PAI/ PR programme? 
Have you ever done pulmonary rehab before? 
This research wanted to test how the PAI/PR programme affected your health.  
During the information collecting sessions with the researcher you wore two activity 
monitors for seven days at home, did a number of questionnaires and completed a walk test. 
How did you find these? 
How confident are you that you could continue to exercise or do physical activity on your 
own now that the programme has finished? 
Would you recommend the PAI/ PR programme to anyone else who has COPD? (optional 
question) 










eTable 5 – Screening data, reasons for exclusion from the LIVELY study in COPD 
Exclusion criteria 
 
Number of participants (n=601) 
Not meeting criteria 
 
COPD not primary Dx 
 







unable to comprehend or follow instruction 





120 [e.g. black outs, MSK 
problems, gait pattern means ped 
may not work, torn Achilles, 
fibromyalgia and 2 sticks for 
walking, chronic back P, severe 
depression, cardic issues/angina, 
epilepsy, Int claudication , wheel 
chair, LTOT and rollator],  
19 [e.g. pulmonary exacerbation 
or any change in symptoms or 
medication in the last four weeks 
resulting in the patient being 
deemed clinically unstable by the 




 Declined to participate 
 
wanted PR as planned 
not interested in PR 
other health issues perceived by patient 
time commitments 
unknown 
unwilling to take part in research 
family/carer/social reasons 
unwilling due to additional assessments  
















did not attend PR information session 
unable to contact 





referred to incorrect PR site 
Did Not Attend Outcomes Assessment 







27 [e.g. awaiting lung Sx, wrong 





Non reported 2 



















61.1 (8.5) 67.2 (7.8) 
Gender (m:f) 24:25 13:10 11:15 
BMI  (kg/m
2) 
27.8 (7.0) 27.3 (7.4) 28.4 (6.8) 
Medicine use  
Respiratory medication only 
7.9 (3.8)  
3.3 (0.9)  
7.2 (3.6) 
3.5 (0.8) 
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Living with family  32     12 20  
FEV1 L/min Mean (±SD) 























CAT(0-40; a higher score 
indicates a higher severity) 
21.1 (7.5) 23.8(6.9) 18.7( 7.3) 
CAT severity  (frequency) 
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10 
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Previous PR attendance 














19   
















Regularly physically active relates to: Exercise e.g. weight training,  
aerobics for 20 minutes 3 times  per week, OR Sport e.g. golf, hockey, netball, athletics, swimming  
for 20 minute  3 times per week,  OR General e.g. walking, cutting the grass, vacuuming, washing the  
car  accumulating to at least 30 minutes 5 times per week. SOC Questionnaire: Stage 1 - I am not   
regularly PA and do not intend to be so in the next  6months;   
Stage 2 - I am not regularly PA but am thinking about starting to do so in the next 6 months; Stage 3 I  
do some PA but not enough to meet the description of regularly PA given above; Stage 4 -I am  
regularly PA but only began in the last 6 months; Stage 5 -I am regularly PA and have been for longer  
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SOC Questionnaire  
(frequency) 
Stage 1  
Stage 2  
Stage 3  
Stage 4  






















Outcome Measure and reasons 
for missing data  
PAI Baseline N=23 PR Baseline N=26 PAI Post intervention 
N=18 
PR Post intervention 
N=19 
PAI  Follow up 
N=15 
PR Follow up 
N=18 
Actigraph Available N=17 Available N=23 Available N=14 Available  N=12 Available N=12 Available N=14 
Not meeting wear time criteria (5 
days of ten hours) 
N=3  N=3  N=2  N=2  N=2  N=4  
Patient non-compliant with 
wearing device 
N=1       
Researcher error in download N=2   N=1  N=3    
Paper base outcomes only   N=1  N=1  N=1   
Actigraph error    N=1    
Pedometer Available N=22 Available N=20 Available N=16 Available N=13 Available N=10 Available N=13 
Not meeting wear time criteria ( 5 
days of 100-50,000 steps) 
 N=6  N=1  N=5  N=4  N=5  
Patient non-compliant with 
wearing device 
N=1       
Paper based outcomes only   N=1  N=1  N=1   
IPAQ Available N=23 Available N=26 Available N=18 Available  N=18 Available N=15 Available N=17 
Unable to complete (unwell)    N=1   N=1  
GROC   Available N=13 Available N=13 Available N=11 Available N=9 
eTable 7 Available outcome measures at each time point and reasons for any missing data 
 
Outcome measure added to CRF 
after visit had been completed 
  N=4  N=5   N=4  N=8  
Unable to complete (unwell)   N=1  N=1   N=1  
CAT Available N=23 Available N=26 Available N=27 Available N=19 Available N=15 Available N=18 
Not available in CRF   N=1     
EQ5D5L Available N=23 Available N=26 Available N=18 Available N=19 Available N=15 Available N=17 
Unable to complete (unwell)      N=1  
ISWT Available N=23 Available N=26 Available N=16 Available N=16 Available N=14 Available N=17 
Paper based outcomes only 
completed 
  N=1  N=1 N=1   
Unable to travel   N=1  N=1   N=1  
Removed- outlier    N=1   
Semi structure interviews   Available N=16 Available N=16   
Paper based OMs only    N=1 N=1   
Did not start intervention     N=2   
Dropped out (study withdrawal)   N=5 N=5   
Unable to travel    N=1 N=1   
LTF    N=2   
eTable 8 Results of participant outcome measures (Actigraph, Sealed pedometer, IPAQ and 
GROC, ISWT, CAT and EQ5D5L) for the PAI group and PR group at baseline and post 
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 IPAQ 
category 
score - High 
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*Not meeting criteria (Actigraph: 5 days of ten hours wear time, pedometer: 100-50,000 steps  
recorded) Ʃ patient non-compliant with wearing device ® researcher download error.π: paper based  
outcomes only completed. β Actigraph error, α:unable to travel as unwell and unable to travel, #  
outcome measure added to CRF post visit Ω Outcome measure not available in CRF, α:unable to  
complete as unwell and unable to travel, **n=1 outlier
56 
 
 
